Computed tomography showed large masses in both adrenal glands, and bilateral uptake was identified on adrenal scintigraphy. The totals for the bilateral adrenal glands were 98 g and 105 g, respectively, and the left adrenal was larger than the right in both cases. Steroid content in the nodules measured by high performance liquid chromatography (HPLC) showed that the cortisol content was definitely lower than that in cortisol-producing adenoma (CPA) and even in normal adrenals. The activities of cytochrome P450c17, P450c21 and P450c11 were evaluated in one case, and all of them were reduced in the nodules.
A significant increase in plasma cortisol levels in response to ACTH stimulation was observed in both cases. After the administration of metyrapone in one case, urinary excretion of 17-hydroxycorticosteroid (17-OHCS) significantly increased, although the plasma ACTH level did not respond.
Computed tomography showed large masses in both adrenal glands, and bilateral uptake was identified on adrenal scintigraphy. The totals for the bilateral adrenal glands were 98 g and 105 g, respectively, and the left adrenal was larger than the right in both cases. Steroid content in the nodules measured by high performance liquid chromatography (HPLC) showed that the cortisol content was definitely lower than that in cortisol-producing adenoma (CPA) and even in normal adrenals. The activities of cytochrome P450c17, P450c21 and P450c11 were evaluated in one case, and all of them were reduced in the nodules.
Especially that of P450c17 was remarkably reduced. These data suggest that cortisol production in AIMAH is inefficient, and that the cause of Cushing's syndrome may be related to the marked increase in the number of cells or bulk of the tumor.
Key words: ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) After the basal level and diurnal rhythm of plasma ACTH and cortisol (F) were examined, 2 mg of dexamethasone (DXM) was administered every 6 h for a total of 4 doses, and plasma F was measured the next morning (0800 h), in a highdose DXM suppression test. Urinary excretion of 17-hydroxycorticosteroid (17-OHCS) and 17-ketosteroid (17-KS) was also measured. Plasma F levels were measured at 0, 30 and 60 min after a bolus injection of 0.25 mg of 1-24 ACTH (rapid ACTH test). Responses of plasma ACTH and urinary excretion of 17-OHCS were examined after 500 mg of metyrapone was administered every 4 h for a total of 6 doses (metyrapone test). Plasma levels of aldosterone, corticosterone (B), 11-deoxycorticosterone (DOC), progesterone (P), 17-hydroxyprogesterone (17-OH P) and plasma renin activity (PRA) were also measured in the morning (0800 h) after 15 min of bed rest. Plasma levels of F, aldosterone and PRA were measured with commercially available radioimmunoassay (RIA) kits (Nihon Kodak, Daiichi Radioisotope and SRL, Japan, respectively). The plasma ACTH level was measured with an immunoradiometric assay kit (Mitsubishi Yuka Medical, Japan). Plasma levels of P, 17-OH P, B and DOC were determined by RIA with specific antisera to 3-(0-carboxymethyl) oxime-BSA of each steroid (Teikoku Hormone, Mfg., Japan).
Measurement of steroid content in adrenals
Steroid levels in adrenal nodules of AIMAH, CPA and normal control adrenals were analyzed by the HPLC system which we reported previously [9] .
Measurement of enzyme activity
Microsomal and mitochondrial fractions were prepared from the nodules of AIMAH, CPA and the normal control adrenals by differential centrifugation [10] .
Assay of P450c17 and P450c21 activity
The assay was performed as described by Shibata and Suzuki et al. [11, 12] . The microsomal fraction (30-60 µg of protein) was incubated with 100 µmol/l of progesterone (P450c17) or 17-hydroxyprogesterone (P450c21) as the substrate, and 5 mmol/l isocitrate, 0.5 units/ml of isocitrate dehydrogenase, and 5 mmol/l MgCl2 as an NADPH-generating system, resolving into 100 mmol/l of potassium phosphate buffer containing 0.1 mmol/l EDTA (pH 7.4). The total volume of the incubation mixture was 200 µl. The reaction was initiated by adding NADPH (final concentration, 0.6 mmol/l) and was terminated by adding dichloromethane. The reaction product was extracted with dichloromethane and analyzed by HPLC on a reversed-phase column (YMC AQ-312, 6 mm x 150 mm, YMC, Co., Ltd., Japan) with 45% acetonitril as the mobile phase [9] . Five hundred ng (1.2 nmol) of spironolactone was used as the internal standard.
Assay of cytochrome P450c11 and P450aldo
The mitochondrial fraction (30-60 ,ug of protein) was disrupted by freezing and thawing. In a reconstituted enzyme system including 100 umol/l DOC as a substrate, 14 ,umol/l bovine adrenodoxin, 0.3 umol/l NADPH-adrenodoxin reductase as an electron transport system, 5 mmol/l isocitrate, 0.5 units/ml of isocitrate dehydrogenase, and 5 mmol/l MgCl2 as an NADPH-generating system were dissolved in 100 mmol/l potassium phosphate buffer containing 0.1 mmol/l EDTA (pH 7.4). The final volume of the incubation mixture was 100 ,ul. The reaction was initiated by adding NADPH (final concentration, 0.6 mmol/l) and terminated by adding dichloromethane.
The reaction product was extracted with dichloromethane and analyzed by HPLC on the same column and with the mobile phase as described above. We used 1.33 nmol (500 ng) of methylpredonisolone as the internal standard.
The data are expressed as the means ± SD, and a statistical analysis was performed with Student's t-test.
Case Reports and the right and left adrenals weighed 44 g and 54 g, respectively. The cut surface showed many yellow nodules, 1-3 cm across, but did not contain hemorrhage or necrosis macroscopically (Fig. 2a,  b) . These nodules were pathologically proven to be composed of two different cell types. These included cells with clear cytoplasma forming cord or nest-like structures (major component, 70-80%), and compact cells forming small island-like structures (minor component, 20-30%). No nuclear pleomorphism or mitosis was observed (Fig. 2c) . A normal cortical structure was identified, but it was noticeably atrophic. Although hypertension and NIDDM improved postoperatively, plasma ACTH remained at an undetectable level 12 months after the operation under the replacement therapy with 25 mg of hydrocortisone. A 62-year-old man had been followed up for hypertension and non-insulin-dependent diabetes mellitus (NIDDM) since March, 1987. Obesity and edema in the lower extremities appeared in March, 1992. Since clinical symptoms such as moon-face and central obesity became gradually evident, he was admitted to the hospital in March, 1993. His blood pressure was 174/118 mmHg, and height and weight were 160 cm and 63 kg. Routine blood tests showed hyperglycemia and mild anemia, but serum electrolytes were within the normal range. Endocrine studies revealed suppressed plasma ACTH and diminished circadian rhythm of plasma F. Plasma levels of F were constantly high without relation to meal intake.
Although the plasma aldosterone concentration (PAC) was low, DOC was slightly high. Urinary excretion of 17-KS was within the normal range, whereas that of 17-OHCS was remarkably high. The plasma F in the highdose DXM suppression test showed a nonsuppressed level. A rapid ACTH test revealed a positive response of plasma F (Table 1) . A CT scan showed bilateral large adrenal masses (Fig.  1a) , and a T1-weighted MRI image also revealed low-intensity masses in both adrenal glands which were as enhanced as in the kidney by the injection of gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) (Fig. 1b) 
Results
Since there are many nodules and some histological differences in the ratio of clear cells to compact cells, we analyzed steroid contents in 3 different regions in each adrenal in case 1, but only 2 in case 2. In case 1, the activity of steroidogenic enzymes was also evaluated. In case 1, the F content was much less than that in CPA and even in normal control adrenals.
On the other hand, the level of B was lower than that in normal adrenals, but greater than that in CPA. The 17-OH P content was also lower than that in normal controls and CPA, whereas that of P was not reduced.
F and B content was greater in the left adrenal than in the right. In case 2, F content was also less than that in normal adrenals and CPA. On the other hand, B content was greater than that in CPA and almost equal to that in normal adrenals. Levels of 44-androstenedione were extremely low (undetectable) in both cases (Table 2) . In case 1, the activity of P450c17 was nearly one-tenth of that in normal adrenals and CPA, and the left adrenal showed greater activity than the right as cortisol content on each side. P450c21 activity was also reduced in the right adrenal, but that of the left was almost equal to normal adrenals. P450c11 activity was also less than in normal adrenals and even in CPA. On the other hand, P450c21 activity was significantly increased in CPA, unlike AIMAH. We could not identify the activity of aldosteronesynthesizing enzyme (P450aldo) in any sample in the present study ( syndrome [14] , pituitary lesions which produce ACTH are absent in a majority of pathologically and endocrinologically proven AIMAH [4, 5] . On the other hand, AIMAH should be differentiated from other types of macronodular adrenal hyperplasia such as GIP-dependent Cushing's syndrome [6, 7] . As to this problem, in the present cases, the plasma cortisol levels were constantly high without relation to meal intake, and positive responses of plasma F to ACTH administration were observed as in previous reports [2, 4, 5] . Regarding the characteristic findings in endocrine studies of AIMAH, suppressed plasma ACTH with autonomous secretion of F, and a lack of response of ACTH or F to corticotropin-releasing hormone (CRH), which are findings common to CPA, are usually observed [2] [3] [4] [5] . As to the metyrapone test in patients with AIMAH, Aiba [4] and Cheitlin [1] reported paradoxical findings, that is, a positive response of urinary 17-OHCS or plasma 11-deoxy- 
